These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 17469105

  • 1. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, Hutin P, Renaudineau Y, Dueymes M, Loisel S, Berthou C, Saraux A, Youinou P.
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [Abstract] [Full Text] [Related]

  • 2. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
    d'Arbonneau F, Pers JO, Devauchelle V, Pennec Y, Saraux A, Youinou P.
    Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
    [Abstract] [Full Text] [Related]

  • 3. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
    Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC.
    Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
    [Abstract] [Full Text] [Related]

  • 4. Will targeting B cells be the answer for Sjögren's syndrome?
    Looney RJ.
    Arthritis Rheum; 2007 May; 56(5):1371-7. PubMed ID: 17469093
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO.
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
    Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO.
    Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
    [Abstract] [Full Text] [Related]

  • 9. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells.
    Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, Pers JO.
    J Immunol; 2009 Mar 15; 182(6):3540-7. PubMed ID: 19265132
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2010 Apr 15; 62(4):960-8. PubMed ID: 20131246
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2005 Sep 15; 52(9):2740-50. PubMed ID: 16142737
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects.
    Larsson A, Bredberg A, Henriksson G, Manthorpe R, Sallmyr A.
    Scand J Immunol; 2005 Jan 15; 61(1):98-107. PubMed ID: 15644129
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
    Pontarini E, Fabris M, Quartuccio L, Cappeletti M, Calcaterra F, Roberto A, Curcio F, Mavilio D, Della Bella S, De Vita S.
    Rheumatology (Oxford); 2015 Aug 15; 54(8):1429-34. PubMed ID: 25740829
    [Abstract] [Full Text] [Related]

  • 17. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N, Bootsma H, Yuvaraj S, Spijkervet FK, Haacke EA, Pollard RP, Visser A, Vissink A, Kallenberg CG, Kroese FG, Bos NA.
    Ann Rheum Dis; 2012 Nov 15; 71(11):1881-7. PubMed ID: 22615459
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.